Scientists working In a lab at night seen by the outside of the building

Novartis Financial Results – Q3 2023

Novartis announced the company’s financial results for the third quarter of 2023.
Team meeting

About Us

At Novartis, we are united by a single purpose to reimagine medicine to improve and extend people’s lives.
Scientist in lab

Beacon of Hope

Novartis is expanding the Beacon of Hope program through new collaborations to address systemic health disparities.

Learn more
Man with headset sitting inside an office smiling

Patient Support for Oncology

Novartis Patient Support for Oncology can help you on treatment.
A photo of people in a meeting hall

Contact Us

Find information on our research locations and corporate offices in US.
us careers image_0

Careers

769 million lives touched by our products. Join us.

Latest News

Dec 11, 2023

Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)

Dec 08, 2023

Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions

Dec 06, 2023

Novartis receives FDA approval for Fabhalta® (iptacopan), offering superior hemoglobin improvement in the absence of transfusions as the first oral monotherapy for adults with PNH
View more